The IBMS has welcomed the news that the government plans to invest £160m in the life sciences.
The news comes following an independent review by geneticist Sir John Bell.
Sarah May, IBMS Deputy Chief Executive, said: “The Institute of Biomedical Science welcomes the government’s recognition that investment in life sciences and diagnostics is key to ensuring that patients have access to the best treatments available.
“We will continue to press the message that proper investment in research and laboratory diagnostic services is the key to delivering better diagnosis and treatment.
“The UK has a wealth of good scientists graduating from our accredited biomedical science degrees that will be undertaking the research, developing treatment trials, using the new technologies and sharing best practice that will shape the delivery of our health and social care system.”